Comprehensive needs, social support, and disease perception in lung cancer patients treated with immune checkpoint inhibitors: a cross-sectional study
Menée par questionnaire auprès de 141 patients atteints d'un cancer du poumon traité par inihibiteurs de point de contrôle immunitaire, cette étude transversale analyse l'association entre leurs perceptions de la maladie, leurs besoins en soins de support et le soutien social
Purpose: The aim of this study was to investigate the comprehensive needs of lung cancer patients treated with immune checkpoint inhibitors and to explore the relationships between comprehensive needs and social support and disease perception, moreover, to analyse associated factors of comprehensive needs. Methods: The study was conducted in a teaching hospital in Jiaxing Province, China. A total of 141 patients with lung cancer completed a battery of self-report questionnaires, including the Comprehensive Needs Assessment Tool in Cancer for Patients (CNAT), Social Supportive Rating Scale (SSRS), Brief Illness Perception Questionnaire (BIPQ), and demographic and clinical characteristics questionnaire. Results: The level of comprehensive needs was highest in the domain “medical demand” (42.17 ± 26.57), and the item with the highest level of comprehensive needs was “I need information about the financial support for my medical expenses” (2.00 ± 1.07). Statistically significant correlations were identified between the comprehensive needs score, social support, and disease perception. The multiple regression analysis showed that immunotherapy course, whether irAEs occur, social support, and disease perception were factors influencing patients’ comprehensive needs. Conclusions: The most prevalent needs in lung cancer patients were found in the “medical needs” domain. Additionally, immunotherapy course, whether irAEs occur, disease perception, and social support were associated with comprehensive needs among lung cancer patients. It is essential to combine the associated factors to accurately evaluate patient needs. We should pay more attention to proposing the comprehensive measures for these patients and providing more individualized supportive care during the lengthy treatment period.